This research mainly focus on developing an efficient product that will be effective for remediation during groundwater treatment.
It gives in-depth analysis on in-situ oxidation techniques for groundwater remediation.
High- performance Liquid Chromatography”/
(High- pressure Liquid Chromatography) is a powerful tool in analysis, it yields High Performance and high speed compared to traditional columns chromatography
This research mainly focus on developing an efficient product that will be effective for remediation during groundwater treatment.
It gives in-depth analysis on in-situ oxidation techniques for groundwater remediation.
High- performance Liquid Chromatography”/
(High- pressure Liquid Chromatography) is a powerful tool in analysis, it yields High Performance and high speed compared to traditional columns chromatography
Stationary Phase and Mobile Phase Selection for Liquid Chromatography
The presentation focuses on how to choose the appropriate mode of separation, the correct column and highlights the importance of the correct mobile phase. This approach will be applied to a wide selection of compound types ranging from proteins, peptides, glycans to small pharmaceutical molecules and their metabolites. It will also look at specific application areas for monoclonal antibody analysis, namely: titer, aggregation, charge and oxidation variant. Platform methods for biologics characterization are also discussed.
In this presentation, we tried to cover all the information regarding Reverse Osmosis technology. We have discussed its different types, major parts of Reverse Osmosis i.e Activated Carbon Bed, Ion Exchange Unit, Cartridge Filter and then at the end design steps of Reverse Osmosis.
Selectivity is the KEY
Mixed-mode chromatography addresses unmet challenges in pharmaceutical analysis:
API and counter ion by RP/AEX/CEX trimodal columns (e.g. Acclaim Trinity P1 and P2)
Unique Charged Aerosol Detector for consistent response of analytes that are weak or non-chromophoric molecules
Unmatched performance for counter ion analysis by dedicated column technology, unique charged aerosol detection and established UltiMate 3000 technology
New IonCount complete solution for ease of use and quick methods development of new API and counter ion analysis
Easy operation by predefined eWorkflows, Thermo Scientific™ Dionex™ Chromeleon™ 7.2 Chromatography Data System, and viper connection tubing
Presentation Outline
• Challenges in pharmaceutical analysis
• Mixed-mode chromatography overview
• Mixed-mode chromatography for pharmaceutical analysis
• API and counter ions
• Thermo Scientific™ Dionex™ Corona™ Veo™ Charged Aerosol Detector
• Near universal, mass sensitive detector for routine Liquid Chromatography determinations of any non-volatile and many semi-volatile analytes
• Ion-Count Solutions
• Unmatched performance for counter ion analysis by dedicated column
technology, unique charged aerosol detection and established Thermo
Scientific™ Dionex™ Ultimate™ 3000 High Performance Liquid Chromatography technology
•Summary
Stationary Phase and Mobile Phase Selection for Liquid Chromatography
The presentation focuses on how to choose the appropriate mode of separation, the correct column and highlights the importance of the correct mobile phase. This approach will be applied to a wide selection of compound types ranging from proteins, peptides, glycans to small pharmaceutical molecules and their metabolites. It will also look at specific application areas for monoclonal antibody analysis, namely: titer, aggregation, charge and oxidation variant. Platform methods for biologics characterization are also discussed.
In this presentation, we tried to cover all the information regarding Reverse Osmosis technology. We have discussed its different types, major parts of Reverse Osmosis i.e Activated Carbon Bed, Ion Exchange Unit, Cartridge Filter and then at the end design steps of Reverse Osmosis.
Selectivity is the KEY
Mixed-mode chromatography addresses unmet challenges in pharmaceutical analysis:
API and counter ion by RP/AEX/CEX trimodal columns (e.g. Acclaim Trinity P1 and P2)
Unique Charged Aerosol Detector for consistent response of analytes that are weak or non-chromophoric molecules
Unmatched performance for counter ion analysis by dedicated column technology, unique charged aerosol detection and established UltiMate 3000 technology
New IonCount complete solution for ease of use and quick methods development of new API and counter ion analysis
Easy operation by predefined eWorkflows, Thermo Scientific™ Dionex™ Chromeleon™ 7.2 Chromatography Data System, and viper connection tubing
Presentation Outline
• Challenges in pharmaceutical analysis
• Mixed-mode chromatography overview
• Mixed-mode chromatography for pharmaceutical analysis
• API and counter ions
• Thermo Scientific™ Dionex™ Corona™ Veo™ Charged Aerosol Detector
• Near universal, mass sensitive detector for routine Liquid Chromatography determinations of any non-volatile and many semi-volatile analytes
• Ion-Count Solutions
• Unmatched performance for counter ion analysis by dedicated column
technology, unique charged aerosol detection and established Thermo
Scientific™ Dionex™ Ultimate™ 3000 High Performance Liquid Chromatography technology
•Summary
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Analytical HPLC method development .pdf
1. ANALYTICAL HPLC METHOD DEVELOPMENT
Suchitra Ravan
Ad Hoc Scientific-
Acompanywith apurpose
This presentationis a property of Ad Hoc Scientific Pvt Ltd
2. Overview of HPLC Method DevelopmentStrategy
• Development approach
• Separation goal
• Nature of sample
• Sample pre treatment
• Sample detection
This presentationis a property of Ad Hoc Scientific Pvt Ltd
3. • Development approach
• Theoretical
• Empirical
• Theoretical Vs. Empirical
Thinking Experience
This presentationis a property of Ad Hoc Scientific Pvt Ltd
4. • Resolution
• Peak tailing
• Plate Counts
• Retention Time
• Run time
• Relative Standard deviation
• Separation Goal
This presentationis a property of Ad Hoc Scientific Pvt Ltd
5. • Nature of Sample
• How many number of components present in a
sample?
• What is the chemical structure?
• What is molecular weight?
• Is compound neutral ? ( no buffer in mobile phase)
• Does it undergo ionization?
• What is pka of compound?
• Does is UV active? How is UV spectra?
• How is the solubility?
This presentationis a property of Ad Hoc Scientific Pvt Ltd
6. • Sample pre-treatment
• It is ready for injection?
• Does it need dilution?
• Does it need buffering/ stabilization?
• Does it need dissolution & Extraction?
This presentationis a property of Ad Hoc Scientific Pvt Ltd
7. • Sample Detection
• Chromophoric – UV
• Non chromophoric- Refractive index
Evaporative light scattering
Fluorescence
• Characteristics of Universal detectors
This presentationis a property of Ad Hoc Scientific Pvt Ltd
8. • HPLC Mode
• Reversed Phase HPLC
• Normal Phase HPLC
• Hydrophilic-Interaction Chromatography [HILIC]
• Hydrophobic-Interaction Chromatography [HIC]
• Ion-Exchange Chromatography [IEC]
• Size-Exclusion Chromatography [SEC]
This presentationis a property of Ad Hoc Scientific Pvt Ltd
9. • Solvent Selectivity
• Change in organic solvent
• Change in pH
• Change in buffer
• Buffer capacity
• HPLC method development effect of mobile phase in
Reverse Phase HPLC
This presentationis a property of Ad Hoc Scientific Pvt Ltd
10. • Solvent Selectivity
• Solvent Selectivity triangle
Basic
Acidic Dipolar
• Solvent strength
This presentationis a property of Ad Hoc Scientific Pvt Ltd
11. • Change in organic solvent
• There are 2 types of organic solvent
1. Protic Solvents
Ex- water, ethanol, methanol, ammonia, acetic acid
2. Aprotic Solvents
Ex- acetone, dimethyl sulfoxide, DMF
This presentationis a property of Ad Hoc Scientific Pvt Ltd
12. • Change in pH
• The pH range most often used for reversed phase
can be divided into
1. low pH (1-4)
• Minimum Peak Tailing
• Rugged methods
• Most recommended
2. intermediate pH (4-8)
• Choose wisely considering the pKa of the
compound
3. Extreme cases (8-10.5)
• Harshness will compromise column lifetimes.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
13. • The mobile phase pH can have a dramatic effect on the
ionization state of analytes
• At a pH equal to its pka, an analyte will be in both ionized &
neutral states, resulting in poor chromatography.
• Effects on a basic compound:
• Impact of pH on Acidic & Basic analyte.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
14. • Buffers for Reverse phase HPLC
pH Range Buffer UV cutoff (nm)
1.1-3.1 Phosphate 210
6.2-8.2 Phosphate 210
11.3-13.3 Phosphate 210
2.1-4.1 Citrate 250
3.7-5.7 Citrate 250
4.4-6.4 Citrate 250
3.8-5.8 Acetate 230
7.3-9.3 Tris
(hydroxymethyl)
aminomethane
220
8.2-10.2 Borate 210
This presentationis a property of Ad Hoc Scientific Pvt Ltd
17. • Selection of HPLC Columns
• Introduction
• Type of Silica
• Stationary phases
• Column length
• Column diameter
• Particle Size
• Pore Size
• Surface area
• Carbon load
This presentationis a property of Ad Hoc Scientific Pvt Ltd
18. • Introduction
Silica is heart of HPLC
This presentationis a property of Ad Hoc Scientific Pvt Ltd
19. • Type of Silica
• Type A
Metal contaminants Ni, Al, Zn, Fe
Asymmetry, tailing, change in RT
• Type B
Highly pure, Less acidic
This presentationis a property of Ad Hoc Scientific Pvt Ltd
20. • Stationary phases
• C18
• C8
• C3,C4
• Phenyl
• Amino(NH2)
• Cyano (CN)
This presentationis a property of Ad Hoc Scientific Pvt Ltd
21. • Column Length
•Short (30-50mm) - short run times, low backpressure
•Long (250-300mm) - higher resolution, long
This presentationis a property of Ad Hoc Scientific Pvt Ltd
22. • Column Diameter
•Short ID (30-50mm) – short run times, low backpressure
•Long ID (250-300mm) – higher resolution, long run times
•Narrow ID ( 2.1mm)- high detector sensitivity
•Wide ID ( 10-22 mm)- high sample loading
This presentationis a property of Ad Hoc Scientific Pvt Ltd
23. • Particle Size
•Smaller particles offer higher efficiency, but also cause
higher backpressure.
•Choose 3µm particles to resolve complex, multi-component
samples.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
24. • Pore Size
•Larger pores allow larger solute molecules to be retained
longer through maximum exposure to the surface area of
the particles.
•Choose a pore size of 150Å or less for sample MW 2000.
•Choose a pore size of 300Å or greater for sample MW >
2000.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
25. • Carbon Load
•Higher carbon loads generally offer greater resolution and
longer run times.
•Low carbon loads shorten run times and many show a
different selectivity.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
26. • Column Selection
• To get a separation you must have round about interaction
with the stationary phase.
• Many carbons: choose stationary phase with carbon
Compound: Hydrophobic mode of interaction.
• Acids & bases can be difficult to separate.
• The “neutral” form is usually retained more on a reverse
phase(C18).
• “ionic” form is not retained as much.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
27. • Phenolic phases can be useful when separating
aromatic, polycyclic & unsaturated species.
• Mode of interaction: - interaction between the
electron rich double bonds within the analyte &
stationary phase phenyl moieties.
• NH2 & CN Phases are suggested for separating polar
organic molecules.
• Column Selection
This presentationis a property of Ad Hoc Scientific Pvt Ltd
28. • Column behavior at high pH
• The pH of the mobile phase also affects the stability &
lifetime of a silica based column.
• Neutral/ Basic pH: mechanism of degradation is
dissolution.
• This will be affected by:
1. The type of bonding
2. The type of silica.
3. Mobile phase parameters like buffer strength, organic
composition & operating temperature.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
29. • Acid hydrolysis of the bonded phase from the silica
surface
• Changes in solute retention overtime.
• Increase in rate of hydrolysis with decreasing pH.
• The buffer strength & organic modifier have less of an
effect at low pH than at high pH.
• Column behavior at low pH
This presentationis a property of Ad Hoc Scientific Pvt Ltd
30. • Detector Selection
Detector selection is based on:
• Chemical nature of analytes
• Potential interferences.
Detector’s response to all compounds in the mixture.
• Limit of detection required.
• Availability & cost of detector.
This presentationis a property of Ad Hoc Scientific Pvt Ltd
34. • Contacts
• Suchitra Ravan: 9860138162
Sales.mumbai@adhocscientific.com
info@adhocscientific.com
This presentationis a property of Ad Hoc Scientific Pvt Ltd